Home > Result Summaries: Compounds > Human Papillomavirus Types 16 and 18 Vaccine > Result Summary for 112949

Result Summary for 112949

Result Summary

Protocol ID:	112949
Clinical Study ID:	112949
Official Title:	Long-term extension study of the efficacy of the 580299 vaccine in the prevention of HPV-16 and/or HPV-18 associated cervical intraepithelial neoplasia (CIN) in Japanese women vaccinated in the primary vaccination study NCT00316693
Phase:	phase 3
Study Indications or Diseases:	Human Papillomavirus (HPV)
Generic Name:	Human Papillomavirus Types 16 and 18 Vaccine
Trade/Product Name:	Cervarix
Approved Drug Label:	http://www.gsk.com/products.html
Results Summary:	Click here to download result summary.
Citations:	Konno R et al. 48-month efficacy of the HPV-16/18 AS04-adjuvanted vaccine in young Japanese women. Abstract presented at the European Research Organization on Genital Infection and Neoplasia (EUROGIN), Prague, Czech Republic. 8-11 July 2012.